Brief: Cytodyn Announces Execution Of Exclusive Agreement With American Regent For Distribution And Supply Of Leronlimab For Treatment Of Covid-19 In United States
03/07/2020 23:20
July 3 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN ANNOUNCES EXECUTION OF EXCLUSIVE AGREEMENT WITH
AMERICAN
REGENT FOR DISTRIBUTION AND SUPPLY OF LERONLIMAB FOR TREATMENT
OF COVID-19 IN UNITED STATES
* CYTODYN - SIGNED EXCLUSIVE DISTRIBUTION, SUPPLY AGREEMENT
WITH
AMERICAN REGENT, INC. FOR DISTRIBUTION OF LERONLIMAB FOR
TREATMENT OF COVID-19 IN U.S.
* CYTODYN INC - UNDER TERMS, TO SUPPLY LERONLIMAB FOR
TREATMENT OF
COVID-19 FOR DISTRIBUTION BY AMERICAN REGENT
* CYTODYN INC - UNDER TERMS, TO RECEIVE QUARTERLY PAYMENTS
BASED
ON A PROFIT-SHARING ARRANGEMENT
Source text for Eikon: ID:nGNX89jMyl
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer